Silence Therapeutics (SLN) News Today GBX 535 -5.00 (-0.93%) (As of 11/29/2021) Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period We're Hopeful That Silence Therapeutics (NASDAQ:SLN) Will Use Its Cash WiselyOctober 28, 2024 | finance.yahoo.comSilence Therapeutics (LON:SLN) Stock Price Passes Below 200 Day Moving Average - Time to Sell?October 24, 2024 | americanbankingnews.comSilence Therapeutics files automatic ordinary shares offeringOctober 23, 2024 | markets.businessinsider.comSilence Therapeutics plc (SLNCF)October 19, 2024 | finance.yahoo.comSilence Therapeutics: Strong Buy on Underappreciated Blockbuster Potential and Clinical AdvancementsAugust 30, 2024 | markets.businessinsider.comSilence Therapeutics plc (NASDAQ:SLN) Consensus Forecasts Have Become A Little Darker Since Its Latest ReportAugust 18, 2024 | finance.yahoo.comSilence Therapeutics Second Quarter 2024 Earnings: Misses ExpectationsAugust 17, 2024 | finance.yahoo.comSilence Therapeutics (NASDAQ:SLN) Is In A Good Position To Deliver On Growth PlansMay 21, 2024 | finance.yahoo.comBuy Rating on Silence Therapeutics: Positive Phase 2 Data and Potential for Blockbuster RevenuesMay 17, 2024 | markets.businessinsider.comPause For Effect: Utilize Strategic SilenceMay 2, 2024 | forbes.comNissan to sell tiny Silence Nanocar – and it could come to the UKApril 30, 2024 | msn.comSheryl Sandberg Says ‘Screams Before Silence’ Is the Most Important Work She’s Ever Done: ‘Women’s Bodies Need to Be Protected’ | VideoApril 29, 2024 | yahoo.comBeyond The Numbers: 7 Analysts Discuss Silence Therapeutics StockApril 22, 2024 | markets.businessinsider.comSilence Therapeutics Plc American Depository Share (SLN)April 13, 2024 | nasdaq.com‘Quiet on Set’ to Launch Fifth Episode ‘Breaking the Silence’ With New Drake Bell Interview and MoreMarch 28, 2024 | msn.comSilence Therapeutics plc: Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business HighlightsMarch 13, 2024 | finanznachrichten.deSilence Therapeutics gains on mid-stage win for lead assetMarch 13, 2024 | msn.comSilence Therapeutics Jumps on Clinical TrialsFebruary 23, 2024 | msn.comBroker Revenue Forecasts For Silence Therapeutics plc (NASDAQ:SLN) Are Surging HigherFebruary 7, 2024 | finance.yahoo.comIs Silence Golden for This Small-Cap Biotech Stock?January 31, 2024 | realmoney.thestreet.comSilence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceJanuary 31, 2024 | finance.yahoo.comAll You Need to Know About Silence Therapeutics PLC Sponsored ADR (SLN) Rating Upgrade to Strong BuyJanuary 11, 2024 | msn.comSilence Therapeutics PLC Sponsored ADR (SLN) Is a Great Choice for 'Trend' Investors, Here's WhyJanuary 5, 2024 | finance.yahoo.comThis Silence Therapeutics Insider Increased Their Holding In The Last YearDecember 24, 2023 | finance.yahoo.comHere's Why Momentum in Silence Therapeutics PLC Sponsored ADR (SLN) Should Keep goingDecember 15, 2023 | finance.yahoo.comDoes Silence Therapeutics PLC Sponsored ADR (SLN) Have the Potential to Rally 187.05% as Wall Street Analysts Expect?December 6, 2023 | finance.yahoo.comSilence Therapeutics PLC ADR SLNNovember 21, 2023 | morningstar.comSilence Therapeutics: Bullish Outlook on SLN360 and Future Potential Despite Thalassemia Program DiscontinuationNovember 16, 2023 | markets.businessinsider.comIs This A Miracle Drug For 'Sticky Cholesterol'? Analysts Applaud Safety, Efficacy Of Silence Therapeutics' Heart Disease CandidateNovember 1, 2023 | markets.businessinsider.comSilence Therapeutics ADRs Rise 22% After Positive Trial ResultsNovember 1, 2023 | marketwatch.comEuropean Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday TradingOctober 27, 2023 | msn.comAT&T Unveils “Sound of Silence” Ad to Tout 5G Football Helmet PartnershipOctober 14, 2023 | msn.comSilence Therapeutics to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines ConferenceSeptember 26, 2023 | finance.yahoo.comWhere Silence Therapeutics Stands With AnalystsAugust 17, 2023 | markets.businessinsider.comSilence Therapeutics Plc (NASDAQ: SLN)June 25, 2023 | fool.comThe Latest Analyst Ratings for Silence TherapeuticsMay 11, 2023 | markets.businessinsider.comSilence Therapeutics plc: Silence Therapeutics Appoints Dr. Steven Romano as Incoming Chief Medical Officer and Head of Research and DevelopmentMarch 28, 2023 | finanznachrichten.deSilence Therapeutics plc: Silence Therapeutics to Buyback siRNA Complement AssetsMarch 28, 2023 | finanznachrichten.deSilence Therapeutics to Buyback siRNA Complement AssetsMarch 28, 2023 | finance.yahoo.comSilence Therapeutics Appoints Dr. Steven Romano as Incoming Chief Medical Officer and Head of Research and DevelopmentMarch 28, 2023 | finance.yahoo.comRaquel Leviss breaks her silence, Tom Sandoval finally apologizes to Ariana Madix: Here's the 'Scandoval' latestMarch 10, 2023 | yahoo.comSilence Therapeutics to Present at SVB Securities Global Biopharma ConferenceFebruary 8, 2023 | finance.yahoo.comSilence Therapeutics Appoints J.P. Gabriel as Chief Technical Operations OfficerFebruary 6, 2023 | wsj.comSilence Therapeutics Provides SLN360 and SLN124 Clinical Program UpdatesJanuary 12, 2023 | finance.yahoo.comSilence Therapeutics plc: Silence Therapeutics Reports Third Quarter 2022 ResultsNovember 10, 2022 | finanznachrichten.deSilence Therapeutics Announces Preliminary Single Dose Results from SLN124 Phase 1 Study in Patients with ThalassemiaSeptember 29, 2022 | finance.yahoo.comSilence Therapeutics to Participate in Fireside Chat at Chardan Genetic Medicines ConferenceSeptember 27, 2022 | finance.yahoo.comSilence Therapeutics plc: Silence Therapeutics Announces Pricing of Underwritten OfferingAugust 13, 2022 | finanznachrichten.deSilence Therapeutics PLC ADRJuly 15, 2022 | wsj.comSilence Therapeutics (NASDAQ:SLN), Short Interest ReportJune 17, 2022 | benzinga.com Get Silence Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter. Email Address Sell NVDA Now? (Ad)Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%. Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). SLN Media Mentions By Week SLN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLN News Sentiment▼1.020.44▲Average Medical News Sentiment SLN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLN Articles This Week▼10▲SLN Articles Average Week Get Silence Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GRI News ITH News INDV News BMY News GPH News IGC News PHAR News KOD News AURA News ARTL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:SLN) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silence Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Silence Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
